Accelerating Time-to-Market: Leveraging India's Clinical Trial Capabilities

Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

India has risen as a pivotal contributor in this arena, providing distinct benefits that can be utilized to fast-track the creation and sanctioning of novel treatments.

Role of Data in Advancing Personalized Medicine for Animals

Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

The approach of precision medicine is designed for healthcare customization, with treatments being specifically designed to match the distinct genetic makeup, habits, and environmental exposures of each patient

Achieving NABH Accreditation: Best Practices for Healthcare Providers

Darshan.K, Assistant Editor, India Pharma Outlook

As of 2023, over 800 hospitals in India have achieved NABH accreditation, reflecting a growing emphasis on quality healthcare. NABH accreditation is not just a prestigious certification but a comprehensive framework designed to enhance patient...

How Indian Pharma Companies can Boost Global Market Access

Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

The Indian pharmaceutical industry is currently investing a lot into innovation in order to keep up with the global competition. Many companies are focusing on development of novel drug delivery systems.

The Role of Biomarkers in Modern Drug Discovery

Janifha Evangeline, Assistant Editor, India Pharma Outlook

A novel biomarker for alzheimer's disease in its asymptomatic phase has been discovered in a study that was conducted by the Molecular and Cellular Neurobiotechnology group at the University of Barcelona & the

Implications of US FDA and EMA Standards on Indian Pharma Exports

Darshan.K, Assistant Editor, India Pharma Outlook

Meeting the US FDA and EMA standards demands significant investment in quality management systems (QMS), infrastructure and training. Pharmaceutical companies must ensure that their manufacturing facilities, processes, and products comply with CGM...

© 2025 India Pharma Outlook. All Rights Reserved.